#Ryoncil #Mesenchymal Stromal Cells #Tasly

The Rollercoaster Journey of Mesenchymal Stromal Cells and Their Impact on Medicine

In recent years, the subject of mesenchymal stromal cells (MSCs) has captured the attention of the medical community, thanks to groundbreaking research and significant developments in therapies. The approval of Ryoncil, the first MSC drug by the U.S. FDA, has propelled both excitement and controversy in equal measure due to its exorbitant pricing and the complexities surrounding MSCs' identity and functionality.

The Confounded Identity of MSCs

The exploration of MSCs began in the early 1990s when Arnold Caplan coined the term